BioNTech SE - American Depositary Shares (NQ:BNTX)

BioNTech to Present Multiple Program Updates Across Modalities at ESMO Congress 2023

October 16, 2023

From BioNTech SE

Update Regarding Pfizer’s Statement on COMIRNATY-Related Write-Offs

October 16, 2023

From BioNTech SE

MediLink Therapeutics out-licensed global rights for its antibody-drug conjugate candidate to BioNTech in a $1.1 billion agreement. Meanwhile, BioMap formed a collaboration with Sanofi in a deal with...

Price Over Earnings Overview: BioNTech ↗

October 13, 2023

Via Benzinga

A Look Into BioNTech Inc's Price Over Earnings ↗

October 12, 2023

Via Benzinga

Comparative Study: BioNTech And Industry Competitors In Biotechnology Industry ↗

October 05, 2023

Via Benzinga

Week In Review: Two China Biopharmas Announce Billion Dollar Deals ↗

October 14, 2023

Via Talk Markets

The COVID Vaccine Market Is Changing Dramatically. Do Vaccine Stocks Still Make Good Investments? ↗

October 11, 2023

Vaccine revenue may have slipped but could still represent billions of dollars for these companies.

These featured, inventive companies are not only transforming old sectors but also building bridges toward new ones.

7 Innovator Stocks Primed for Exceptional Growth ↗

October 10, 2023

As the rollout of the updated COVID-19 vaccine progresses, some individuals have been surprised by requests for upfront payments ranging from $150 to $200.

Privatized Vaccine Distribution Sparks Confusion, Payment Challenges ↗

October 09, 2023

Via Benzinga

Small Biotech Promosome Drops Lawsuit Against Pfizer, BioNTech in COVID-19 Vaccine Patent Dispute ↗

October 05, 2023

Biotech firm Promosome has agreed to end the lawsuit, which accused the COVID-19 vaccine manufacturers, Pfizer Inc (NYSE: PFE) and BioNTech SE (NASDAQ: BNTX), of patent infrin

Via Benzinga

Topics Intellectual Property Lawsuit

Why Novavax Stock Fell Today ↗

October 04, 2023

Novavax, Inc. (NASDAQ: NVAX) shares are trading lower Wednesday amid a pullback in the stock, which gained Tuesday after the FDA granted Emergency Use Authorization for the company's updated...

Via Benzinga

Cancer Drug Maker 3D Medicines Inc. Trading Higher After Company Announces It Will Repurchase Up To 10% Of Outstanding Shares ↗

October 04, 2023

3D Medicines Inc. was trading 7.2% higher in the Hong Kong Wednesday morning session at HK$5.53 after the company announced that it is buying back up to 10% of its own stock.

Via Benzinga

Short Sellers Are Betting Against Novavax (NVAX) Stock ↗

October 04, 2023

Shorts are betting no one will want Novavax's Covid-19 vaccine, but the pandemic is not yet over, and NVAX stock is cheap.

Novavax Surges After FDA Signs Off On Its Updated Covid Shot, Joining Pfizer, Moderna ↗

October 03, 2023

The company can now join Pfizer and Moderna in launching an updated booster in the U.S.

Via Investor's Business Daily

Novavax Stock Soars On FDA Clearance For Updated Covid-19 Shot: What's Going On? ↗

October 03, 2023

Novavax Inc (NASDAQ: NVAX) shares are surging Tuesday afternoon after the U.S.

Via Benzinga

Nobel Prize Honors Scientists Behind mRNA Vaccines Against Covid-19 ↗

October 02, 2023

Discover the remarkable journey of Nobel Prize laureates Kariko and Weissman, who transformed medicine with mRNA vaccines, and the financial impact on Moderna and Pfizer stocks.

Via Benzinga

3 Stocks to Buy in October That Could Soar More Than 40% Over the Next 12 Months, According to Wall Street ↗

October 01, 2023

Analysts like these stocks for very good reasons.

The fight against COVID-19 isn't over yet, and the two companies remain very much in the battle.

Why Pfizer and BioNTech Stocks Zoomed Higher Today ↗

September 29, 2023

A German court temporarily suspended proceedings in CureVac's IP lawsuit against BioNTech.

Why CureVac Stock Plunged Today ↗

September 29, 2023

Pfizer and BioNTech Receive Health Canada Authorization for XBB.1.5-Adapted Monovalent COVID-19 Vaccine

Topics Lawsuit

September 28, 2023

From BioNTech SE

Biden's Urgent Action Against Antibiotic-Resistant Bacteria - Allocates $100M to Battle Deadly Superbugs ↗

September 27, 2023

U.S. President Joe Biden is set to unveil a $100 million research initiative to tackle the growing threat of drug-resistant bacteria. More than a million people worldwide succumb to infections caused...

Via Benzinga

DNA Stock Alert: Ginkgo Bioworks Announces Major Partnership With Pfizer ↗

September 27, 2023

The deal keeps Ginkgo alive, but its business model of becoming the "Apple Store of Biotech" remains unproven. DNA stock jumped overnight.

With New COVID-19 Boosters in Tow, Which Is the Better Buy: Pfizer, BioNtech, or Moderna Stock? ↗

Updated Covid Vaccine US Rollout Hit by Insurance Coverage Delays - What It Means? ↗

September 20, 2023

As the U.S.

Via Benzinga

September 20, 2023

All three companies should benefit from increased COVID-19 booster sales.

EQNX::TICKER_START (NASDAQ:ONCY),(NASDAQ:MACK),(NASDAQ:INCY),(NASDAQ:MRTX),(NASDAQ:BNTX) EQNX::TICKER_END

Pancreatic Cancer Battle Boosted by $200M VC Firm

September 19, 2023

Via FinancialNewsMedia

Topics Death

10 Health Care Stocks Whale Activity In Today's Session ↗

September 18, 2023

Via Benzinga

BioNTech and CEPI Announce Partnership to Advance mRNA Mpox Vaccine Development and Support CEPI’s 100 Days Mission

September 18, 2023

From BioNTech SE

More Than Half Of Americans Want New COVID-19 Booster, But Ron DeSantis Will Fight Virus With His Charisma Alone ↗

September 15, 2023

New COVID-19 boosters have been approved by the U.S. FDA in the fight against new variants. A new survey showed how likely people are to get new boosters and if they will have their children get...

Via Benzinga

The 3 Most Undervalued Pharma Stocks to Buy in September 2023 ↗

September 14, 2023

Investing in pharmaceutical industry always carries risk, but several pharma stocks have an attractive risk/reward valuation right now.